“Alternative Therapies: Anti-TNF (Infliximab, And Adalimumab) Agents And Radiological Response For Refractory Sarcoidosis”. The Review of Diabetic Studies (September 14, 2025): 768–784. Accessed October 8, 2025. https://www.diabeticstudies.org/index.php/RDS/article/view/653.